Literature DB >> 29800193

Monoclonal Antibodies for Migraine Prevention: Progress, but Not a Panacea.

Elizabeth W Loder1, Matthew S Robbins2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29800193     DOI： 10.1001/jama.2018.4852

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  2 in total

1.  The potential danger of blocking CGRP for treating migraine in CADASIL patients.

Authors:  Irene de Boer; Antoinette MaassenVanDenBrink; Gisela M Terwindt
Journal:  Cephalalgia       Date:  2020-07-13       Impact factor: 6.292

2.  Minimal breast milk transfer of rituximab, a monoclonal antibody used in neurological conditions.

Authors:  Kristen M Krysko; Sara C LaHue; Annika Anderson; Alice Rutatangwa; William Rowles; Ryan D Schubert; Jacqueline Marcus; Claire S Riley; Carolyn Bevan; Thomas W Hale; Riley Bove
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-11-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.